Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

The Changing Faces of Acne : Episode 14

Video

January 11, 2023

Overview of Isotretinoin MOA and Utilization

Author(s):

Joshua Zeichner, MD

Dr Joshua Zeichner reviews the mechanism of action of Isotretinoin and highlights utilization requirements in patients prescribed this treatment.

EP: 1.Expert Perspectives on a Recent Approval in Acne Management

EP: 2.Treatment Selection Considerations for Mild to Moderate Acne

EP: 3.Unmet Needs and the Role of Consensus Guidelines in Acne Management

EP: 4.Future Directions and Practice Pearls for the Management of Acne

EP: 5.Expert Perspective on Tailoring Acne Treatments

EP: 6.Skin Care Regimens for Acne Treatment

EP: 7.Acne Treatment Selection Considerations

EP: 8.Overview of Isotretinoin Use and Indication in Acne Management

EP: 9.Expert Perspective on Available Isotretinoin Formulations

EP: 10.Expert Recommendations for Setting and Managing Acne Treatment Goals with Patients

EP: 11.Overview of Acne Causes and Triggers

EP: 12.Considerations for Generic vs Brand Acne Treatment Formulations

EP: 13.Expert Perspectives on Acne Causes and Triggers

EP: 14.Overview of Isotretinoin MOA and Utilization

EP: 15.Frontline Forum Part 1: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

EP: 16.Frontline Forum Part 2: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

EP: 17.Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

EP: 18.Frontline Forum Part 4: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

EP: 19.Expert Perspective on the Management of Acne

EP: 20.Treatment Selection in Patients with Acne Vulgaris

EP: 21.Differences in Isotretinoin Formulation

EP: 22.Expert Perspective on the Utilization of Clascoterone Cream 1%

EP: 23.Utilization of Isotretinoin in Patients with Severe Acne

EP: 24.Expert Insights into the Safety of Isotretinoin

EP: 25.Overview and Prevalence of Acne Vulgaris

EP: 26.Approaches to Target Sebum Production

EP: 27.Expert Insights into the Use of Isotretinoin

EP: 28.Advances in Acne Management

EP: 29.Expert Opinion on the Utility of Guidelines in Patient Care

EP: 30.Novel Approach to Sebum Production

EP: 31.Expert Insights into the Importance of Active Components in Acne Treatments

EP: 32.Frontline Forum Part 1: A Greater Understanding of the Acne Vulgaris Armamentarium

EP: 33.Frontline Forum Part 2: A Greater Understanding of the Acne Vulgaris Armamentarium

EP: 34.Frontline Forum Part 3: A Greater Understanding of the Acne Vulgaris Armamentarium

EP: 35.Frontline Forum Part 4: A Greater Understanding of the Acne Vulgaris Armamentarium

EP: 36.Discovering Dermatology Times: August 2023 Acne Vulgaris Supplement

EP: 37.Top 5 Clinical Pearls for Acne Vulgaris Management

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Videos

Video 2 - 1 KOL featured in, "Adolescent Acne Management: Strategic Approaches and Leveraging Clascoterone Cream "

Video 1 - 1 KOL featured in, "Comprehensive Acne Management: Exploring the Role of Combination and Food Independent Treatments in an Adolescent Treatment-Naïve Patient "

Heather Woolery-Lloyd, MD, FAAD, an expert on acne

Heather Woolery-Lloyd, MD, FAAD, an expert on acne

Heather Woolery-Lloyd, MD, FAAD, an expert on acne

Related Content

Isotretinoin Often Continued Despite Mood Concerns

April 22nd 2025

Isotretinoin Often Continued Despite Mood Concerns

The Cutaneous Connection- Episode 12: Antibiotics for Acne

November 23rd 2020

The Cutaneous Connection- Episode 12: Antibiotics for Acne

Microneedles Offer a New Hope for Nodular Acne Treatment

April 10th 2025

Microneedles Offer a New Hope for Nodular Acne Treatment

The Cutaneous Connection- Episode 10: Maskne

November 5th 2020

The Cutaneous Connection- Episode 10: Maskne

Fixed-Dose Acne Treatment Gel is Safe and Effective for Hispanic Patients, According to Post-Hoc Analysis

March 28th 2025

Fixed-Dose Acne Treatment Gel is Safe and Effective for Hispanic Patients, According to Post-Hoc Analysis

Topical Xyngari Meets All Primary Endpoints in Phase 3 Study for Moderate to Severe Acne

March 27th 2025

Topical Xyngari Meets All Primary Endpoints in Phase 3 Study for Moderate to Severe Acne

Related Content

Isotretinoin Often Continued Despite Mood Concerns

April 22nd 2025

Isotretinoin Often Continued Despite Mood Concerns

The Cutaneous Connection- Episode 12: Antibiotics for Acne

November 23rd 2020

The Cutaneous Connection- Episode 12: Antibiotics for Acne

Microneedles Offer a New Hope for Nodular Acne Treatment

April 10th 2025

Microneedles Offer a New Hope for Nodular Acne Treatment

The Cutaneous Connection- Episode 10: Maskne

November 5th 2020

The Cutaneous Connection- Episode 10: Maskne

Fixed-Dose Acne Treatment Gel is Safe and Effective for Hispanic Patients, According to Post-Hoc Analysis

March 28th 2025

Fixed-Dose Acne Treatment Gel is Safe and Effective for Hispanic Patients, According to Post-Hoc Analysis

Topical Xyngari Meets All Primary Endpoints in Phase 3 Study for Moderate to Severe Acne

March 27th 2025

Topical Xyngari Meets All Primary Endpoints in Phase 3 Study for Moderate to Severe Acne

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.